Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
04/2012
04/26/2012US20120101028 Anti-inflammatory compounds and uses thereof
04/26/2012US20120100233 Compositions for treatment and prevention of diabetic complications using osteomeles schwerinae
04/26/2012US20120100185 Regeneration of tissue without cell transplantation
04/26/2012US20120100126 Method to Increase the Growth Velocity of Human Infants
04/26/2012US20120100108 Compositions and methods of treating no-option critical limb ischemia (cli)
04/26/2012US20120100099 Fusion proteins having mutated immunoglobulin hinge region
04/26/2012DE102010049036A1 Aqueous solution, useful e.g. for rinsing tissues or organs of human or animal body, and for rinsing eyes or skin wounds, comprises sodium and potassium salts of mono hydrogen phosphate and dihydrogen phosphate
04/26/2012CA2813708A1 Arylamide derivatives as ttx-s blockers
04/25/2012EP2444411A1 Tripeptide boronic acid or boronic ester, preparative method and use thereof
04/25/2012EP2444402A1 Compound having spiro-bonded cyclic group and use thereof
04/25/2012EP2444401A1 Novel imidazopyridine compound
04/25/2012EP2444400A1 Substituted polycyclic carbamoylpyridone derivative
04/25/2012EP2442870A1 Pyrazinooxazepine derivatives
04/25/2012EP1804797B1 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
04/25/2012EP1570847B1 Phosphodiesterase 10a inhibitors for use in the treatment of parkinson's disease, huntington's disease and schizophrenia
04/25/2012EP1505993B1 Sensitization of neoplastic cells to radiation therapy with oncolytic viruses
04/25/2012EP1482933B1 Potent, simplified derivatives of immunosuppressive agents
04/25/2012EP1383490B1 Combination of an epothilone analog and chemotherapeutic agents for the treatment of proliferative diseases
04/25/2012EP1356277B1 Method for altering cell fate
04/25/2012CN1907446B 一种保健组合丹 A health portfolio Dan
04/25/2012CN1537014B HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases
04/25/2012CN102428080A 神经营养因子活性参与的疾病的治疗或预防剂 Neurotrophic agent for treating or preventing diseases associated with the activity of Factor
04/25/2012CN102428069A 丙烯酰胺化合物及其用途 Acrylamide compounds and use thereof
04/25/2012CN102427817A 起因于gne蛋白质功能降低的疾病的治疗用药物、食品组合物、食品添加剂 Due to the decrease in protein function gne treatment of diseases with drugs, food compositions, food additives
04/25/2012CN102427810A 作为trpm8拮抗剂的氨磺酰基苯甲酸衍生物 As trpm8 antagonists sulfamoyl benzoic acid derivative
04/25/2012CN102427807A Anti-obesity agent comprising compound containing benzotropolone ring
04/25/2012CN102424699A 一种新灰毡毛忍冬皂苷及其制备方法和用途 A new macranthoides saponins and its preparation and use
04/25/2012CN102424698A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections
04/25/2012CN102424680A 病毒聚合酶抑制剂 Viral polymerase inhibitors
04/25/2012CN102423402A 一种治疗盗汗的中药组合物 A therapeutic herbal composition sweats
04/25/2012CN102166320B 用于毒郁体质人排毒解郁的中药制剂及其制备方法和应用 Chinese medicine for depression drug detox Jieyu human physique and its preparation method and application
04/25/2012CN102106863B 一种水产养殖用水体泼洒型抗应激剂 One kind of aquaculture water spill anti-stress agent
04/25/2012CN101862357B 山香圆叶总黄酮乙醇回流提取物及其制备方法和用途 Yamaga round leaves flavonoids ethanol extraction and preparation method and uses
04/25/2012CN101849953B 炎症性细胞因子产生游离抑制剂 Inflammatory cytokine production inhibitor free
04/25/2012CN101574395B 一种采用高电压脉冲电场技术生产五味子提取物的方法 A method using high voltage pulsed electric field technology to produce extracts of Schisandra
04/25/2012CN101426774B Azolecarboxamide derivative
04/25/2012CN101397295B 作为组蛋白去乙酰化酶抑制剂的2-吲哚满酮衍生物、其制法和用途 As a histone deacetylase inhibitor 2-indolinone derivatives, their preparation and use
04/24/2012US8163957 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
04/24/2012US8163932 Substituted indolealkanoic acids
04/24/2012US8163805 Small molecule antagonists of Bcl-2 family proteins
04/24/2012US8163751 Acylated indanyl amines and their use as pharmaceuticals
04/24/2012US8163733 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
04/24/2012US8163719 Regulators of the hedgehog pathway, compositions and uses related thereto
04/24/2012CA2645467C Pyridine derivative having anti-helicobacter pylori activity
04/24/2012CA2525373C Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
04/24/2012CA2494179C Pyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
04/24/2012CA2481926C Heterocyclic compounds which inhibit leukocyte adhesion mediated by .alpha.4 integrins
04/24/2012CA2480113C Substituted amino isoxazoline derivatives and their use as anti-depressants
04/24/2012CA2472190C Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof
04/24/2012CA2439149C Acylated piperidine derivatives as melanocortin-4 receptor agonists
04/24/2012CA2433807C Hydrophobic polyamine analogs and methods for their use
04/24/2012CA2433582C Peptides having inhibiting activity on the production of nitric oxide
04/24/2012CA2408752C Delivery systems for treatment of vascular disease
04/24/2012CA2339529C Isolated and purified human soluble guanylyl cyclase .alpha.1/.beta.1 (hsgc .alpha.1/.beta.1)
04/19/2012WO2012051505A1 Treatment of vocal cords with autologous dermal fibroblast formulation
04/19/2012WO2012050895A1 Methods for treating neurological disorders using nutrient compositions
04/19/2012WO2012050184A1 Sustained-release pharmaceutical composition
04/19/2012WO2012050181A1 Prophylactic or therapeutic agent for fibrosis
04/19/2012WO2012050162A1 Cellular life span extending agent, and telomerase activator
04/19/2012WO2012050159A1 Amide derivative and use thereof
04/19/2012WO2012050154A1 Inhibitor of osteoclast formation containing anti-vdac antibody
04/19/2012WO2012050151A1 Acylbenzene derivative
04/19/2012WO2011159781A3 Bitter taste modulators
04/19/2012US20120095277 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
04/19/2012US20120095102 Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof
04/19/2012US20120095049 Nociceptin analogs
04/19/2012US20120095047 Novel Heteropyrrole Analogs Acting on Cannabinoid Receptors
04/19/2012US20120095046 Amido-Isothiazole Compounds and Their Use as Inhibitors of 11Beta-HSD1 for the Treatment of Metabolic Syndrome and Related Disorders
04/19/2012US20120095042 Organic Compounds Having Cooling Properties
04/19/2012US20120095025 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/19/2012US20120095011 Novel compounds
04/19/2012US20120095006 Treatment of pulmonary hypertension
04/19/2012US20120094971 Compositions Including 6-Aminohexanoic Acid Derivatives As HDAC Inhibitors
04/19/2012US20120094970 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
04/19/2012US20120094968 Sulfonic amide and sulfoximine-substttuted diaryl-dihydropyrimidinones and usage thereof
04/19/2012US20120094966 Organic compounds
04/19/2012US20120094959 Treatment of cystic diseases
04/19/2012US20120094955 Method of dissolving an oxidized polysaccharide in an aqueous solution
04/19/2012US20120094938 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
04/19/2012US20120094918 Method of using diketopiperazines and composition containing them
04/19/2012US20120094911 Endokinin c/d-derived peptides
04/19/2012US20120094893 Method of using diketopiperazines and composition containing them
04/19/2012US20120094293 PGC-1ß, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
04/19/2012US20120093866 Formulation for stabilizing proteins, which is free of mammalian excipient
04/19/2012US20120093838 Gene detection assay for improving the likelihood of an effective response to a her2 antibody cancer therapy
04/19/2012US20120093831 Methods and materials for modulating resistance to apoptosis
04/19/2012US20120093795 Compounds targeting the cation-independent mannose 6-phosphate receptor
04/19/2012US20120093794 Methods for Treating Pompe Disease
04/19/2012US20120093778 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
04/19/2012US20120093759 Medical Devices, Wound Dressings, and Methods for Dressing Wounds
04/19/2012US20120093731 Gas-filled microvesicles with targeting ligand or therapeutic agent
04/19/2012US20120091605 Chewable Soft Capsule
04/19/2012CA2814628A1 Acylbenzene derivative
04/19/2012CA2813163A1 Prophylactic or therapeutic agent for fibrosis
04/18/2012EP2441833A1 Aptamer for chymase, and use thereof
04/18/2012EP2441760A1 Compound having detrusor muscle-contracting activity and urethral sphincter muscle-relaxing activity
04/18/2012EP2441753A1 Tetracyclic compound
04/18/2012EP2440560A1 The succinate of tenofovir disoproxil
04/18/2012EP2440546A2 Compounds useful for treating premature aging and in particular progeria
04/18/2012EP2440545A2 Compounds useful for treating cancer
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 1564